The past year has been another extremely challenging one, to say the least. I’d imagine that most committee members have had their full course of COVID vaccinations, and their booster shots too. I haven’t heard about a new round of boosters, but I wouldn’t bet against it!
In the face of these external challenges we have adapted and continued with our regular programme of activities. Virtual and blended meetings have gone ahead, and been tremendously successful, on both a scientific and financial basis, though it has to be said that delegate feedback from the blended meetings suggests there is a strong desire for a return to more physical meetings. The ESG, BMCS Lectureships, Hall of Fame and International Travel Prize Initiatives have carried on, and continued to draw interest from applicants as well as recognition for the impact of the Group. Our links with RSC Medicinal Chemistry have been strengthened, to mutual benefit, as have our interactions with other scientific societies and organisations. Many of the latter have looked to us for our experience and expertise in running virtual and hybrid meetings. I would like to convey my heartfelt thanks to everyone in the group who’s helped to drive these initiatives forward, they wouldn’t be happening without your hard work.